参考文献 |
1: De Prins A, Allaoui W, Medrano M, Van Eeckhaut A, Ballet S, Smolders I, De Bundel D. Effects of neuromedin U-8 on stress responsiveness and hypothalamus- pituitary-adrenal axis activity in male C57BL/6J mice. Horm Behav. 2020 May;121:104666. doi: 10.1016/j.yhbeh.2019.104666. Epub 2020 Mar 2. PMID: 31899262.
2: Masuda Y, Kumano S, Noguchi J, Sakamoto K, Inooka H, Ohtaki T. PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration. Peptides. 2017 Aug;94:99-105. doi: 10.1016/j.peptides.2017.04.001. Epub 2017 Apr 8. PMID: 28400225.
3: Minamino N, Kangawa K, Matsuo H. Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. Biochem Biophys Res Commun. 1985 Aug 15;130(3):1078-85. doi: 10.1016/0006-291x(85)91726-7. PMID: 3839674.
4: Sumi S, Inoue K, Kogire M, Doi R, Takaori K, Suzuki T, Yajima H, Tobe T. Effect of synthetic neuromedin U-8 and U-25, novel peptides identified in porcine spinal cord, on splanchnic circulation in dogs. Life Sci. 1987 Sep 28;41(13):1585-90. doi: 10.1016/0024-3205(87)90725-9. PMID: 3626773.
5: Honzawa M, Sudoh T, Minamino N, Kangawa K, Matsuo H. Neuromedin U-like immunoreactivity in rat intestine: regional distribution and immunohistochemical study. Neuropeptides. 1990 Jan;15(1):1-9. doi: 10.1016/0143-4179(90)90153-p. PMID: 2325835.
6: Hashimoto T, Kurosawa K, Sakura N. Structure-activity relationships of neuromedin U. II. Highly potent analogs substituted or modified at the N-terminus of neuromedin U-8. Chem Pharm Bull (Tokyo). 1995 Jul;43(7):1154-7. doi: 10.1248/cpb.43.1154. PMID: 7586059.
7: Malendowicz LK, Nussdorfer GG, Markowska A, Tortorella C, Nowak M, Warchol JB. Effects of neuromedin U (NMU)-8 on the rat hypothalamo-pituitary-adrenal axis. Evidence of a direct effect of NMU-8 on the adrenal gland. Neuropeptides. 1994 Jan;26(1):47-53. doi: 10.1016/0143-4179(94)90092-2. PMID: 8159286.
8: Domin J, Ghatei MA, Chohan P, Bloom SR. Neuromedin U--a study of its distribution in the rat. Peptides. 1987 Sep-Oct;8(5):779-84. doi: 10.1016/0196-9781(87)90058-1. PMID: 3432125.
9: Kurosawa K, Sakura N, Hashimoto T. Structure-activity relationships of neuromedin U. III. Contribution of two phenylalanine residues in dog neuromedin U-8 to the contractile activity. Chem Pharm Bull (Tokyo). 1996 Oct;44(10):1880-4. doi: 10.1248/cpb.44.1880. PMID: 8904815.
10: De Prins A, Martin C, Van Wanseele Y, Skov LJ, Tömböly C, Tourwé D, Caveliers V, Van Eeckhaut A, Holst B, Rosenkilde MM, Smolders I, Ballet S. Development of potent and proteolytically stable human neuromedin U receptor agonists. Eur J Med Chem. 2018 Jan 20;144:887-897. doi: 10.1016/j.ejmech.2017.12.035. Epub 2017 Dec 14. PMID: 29329072.
|